Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JASON R THONHOFF

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1871885459
CMS profile
221442
Location
HOUSTON, TX

General Payments · PY2018–2024

$62,688.48

  • Reported across 161 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,816.62

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $392.27 16
PY2019 $250.21 14
PY2020 $1,314.78 15
PY2021 $104.71 7
PY2022 $1,942.23 10
PY2023 $52,867.66 83
PY2024 $5,816.62 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amylyx Pharmaceuticals, Inc. $17.76 02/03/2024 Food and Beverage Undisputed 01/23/2026 1148254485 CMS
Amylyx Pharmaceuticals, Inc. $29.96 03/02/2024 Food and Beverage Undisputed 01/23/2026 1148254487 CMS
Biogen, Inc. $171.00 01/02/2024 Consulting Fee Undisputed 01/23/2026 1104862310 CMS
Biogen, Inc. $1,144.00 02/28/2024 Consulting Fee Undisputed 01/23/2026 1104813039 CMS
Biogen, Inc. $4,110.00 05/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104878318 CMS
Biogen, Inc. $21.76 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104848558 CMS
Biogen, Inc. $5.00 06/20/2024 Travel and Lodging Undisputed 01/23/2026 1104834171 CMS
Biogen, Inc. $52.88 06/20/2024 Food and Beverage Undisputed 01/23/2026 1104843940 CMS
Biogen, Inc. $46.88 06/20/2024 Food and Beverage Undisputed 01/23/2026 1104865686 CMS
Biogen, Inc. $24.00 06/20/2024 Travel and Lodging Undisputed 01/23/2026 1104873650 CMS
CATALYST PHARMACEUTICALS, INC. $20.25 03/11/2024 Food and Beverage Undisputed 01/23/2026 1144457217 CMS
CATALYST PHARMACEUTICALS, INC. $36.50 06/03/2024 Food and Beverage Undisputed 01/23/2026 1144457219 CMS
Lilly USA, LLC $63.74 05/29/2024 Food and Beverage Undisputed 01/23/2026 1135031366 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $18.05 07/07/2024 Food and Beverage Undisputed 01/23/2026 1144510712 CMS
Otsuka America Pharmaceutical, Inc. $29.76 04/04/2024 Food and Beverage Undisputed 01/23/2026 1118993788 CMS
Otsuka America Pharmaceutical, Inc. $25.08 05/03/2024 Food and Beverage Undisputed 01/23/2026 1118993790 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.